Dr. Cross (Host):
Welcome to Pete's Cast, a podcast brought to you by Children's
of Alabama in Birmingham.
I'm your host, Dr.
Cory Cross.
Thank you for joining us today.
We'll be speaking with Dr.
Jamie, a, who is recently appointed Director of Developmental Therapeutics at
the University of Alabama at Birmingham.
As Director of Developmental Therapeutics, Dr.
A works to develop novel treatments for children with cancer and blood disorders.
Dr.
A thank you for joining us.
Jamie Aye, MD: Thank you for having me.
Dr. Cross (Host):
So broad picture for those of us who might not know what is
developmental therapeutics.
Jamie Aye, MD: Yeah, that's a great question.
so developmental therapeutics is kinda like it sounds, so it's to develop,
more effective, less toxic therapies for children, particularly those with cancer.
And we do that by trying to bring things from the bench to the bedside.
Dr. Cross (Host):
So it's medications.
Jamie Aye, MD: Yes.
Dr. Cross (Host):
Got it.
And so can you tell us the type of patient's who referred to this
program, And the challenges they face?
Are they all children who are having, cancer or are there specific types of
cancers that This is more, uh, towards?
Jamie Aye, MD: this program is really meant for patient's who
have difficult to treat recurrent, relapsed cancers who have, already
seen, standard therapies and have unfortunately failed those therapies
and need something new and novel, to try and get rid of their cancer.
Dr. Cross (Host):
So when you're working in this type of environment, are you working alongside
other researchers and other hospitals?
Because I'm assuming that the, the.
Patient, load with these different types of cancers, it's very rare.
So how do you get the numbers to make the decisions?
Jamie Aye, MD: Yeah, great question.
So yes, we, have various consortia that are, um.
Either disease specific or perhaps they're specific with regards to
particular genetic, abnormality that's shared amongst a group of cancers.
And, we work in these consortium with other institutions throughout the United
States and elsewhere to come up with those patient numbers to be able to see
if something, will make a difference.
Dr. Cross (Host):
So as Director of Developmental Therapeutics, tell us a little
bit about how this program makes a difference in children's lives.
And sort of what they experience when they come to this clinic.
How is it different than when they're, sort of getting treated the first-time?
Jamie Aye, MD: Yeah.
So I think, it provides the family, with hope that we will find something that will
provide them, With some newer options.
If their cancer hasn't seen, they still come to our regular
clinic, so that doesn't change.
they are able to keep their same primary oncologist if they've been treated here.
We do have referrals from outside facilities for trials here that may not
be available at their home institution.
but I think, just providing families with that hope and hopefully overall,
research over time is able to provide.
Therapies for children with various cancers, in these
difficult to treat scenarios.
Dr. Cross (Host):
Now you've been at this program for a while now.
You are now director, but previously you were associate director.
Can you tell me a little bit about the progress you've seen and, how
you and your team have made, changes over, over that time period?
Jamie Aye, MD: Yeah, so, you know, research certainly takes time and takes
a team, And we are very blessed here at Children's of Alabama to be surrounded
by the University of Alabama, at Birmingham and all the researchers
here, anywhere from researchers.
Within pharmacology or radiology or immunology, genetics.
so, in my time as associate director, we created our annual research pediatric
retreat here, to bring those researchers together so that hopefully we can see
commonalities between the different.
Projects that we're working on so that people aren't siloed and hopefully
can collaborate, with either new technologies, maybe a new biomarker to
be able to measure how much disease, new immunotherapies, maybe new ways
of detecting disease by imaging.
so I think we've helped to start build those collaborations here locally.
and I think that will help us in moving forward.
Dr. Cross (Host):
Do you have any success stories that you can share with us?
Jamie Aye, MD: Not at the moment, but we are definitely working on, our big
goal overall is to create what we call an investigator initiated trial here, at UAB
and Children's of Alabama, in which our.
researchers who work at the bench side, we're able to actually turn
that into a clinical trial where it actually affects a patient.
And so that's our overall big goal.
And we are, in the process of working on some projects and hopefully in the
coming years, those will come to fruition.
Dr. Cross (Host):
Is there anything else the future holds for the program?
Jamie Aye, MD: having those investigator initiated trials And then also
continuing to build with industry.
and different pharmaceutical companies to hopefully bring in new therapeutic
options that way to try And then again, to continue to build our collaborations
with the various consortia and adding to our, portfolio of trials that
we're able to offer our patient's.
Dr. Cross (Host):
Well, that sounds really exciting, to really be on the forefront of this
type of research And what you're able to provide to these kids because it really,
it really is a last resort when you have either some sort of recurring cancer
or you're not responding to treatment.
So to know that they have people fighting for them.
I I'm sure very comforting to them and their families.
Is there anything else you'd like to share with our listeners today?
Jamie Aye, MD: I think just to summarize, you know, developmental
therapeutics, again, the goal is to develop new therapies that are less
toxic, especially for these patient's, with relapsed recurrent disease
that it's very difficult to treat.
and we're hoping to do that again by building these research collaborations,
both here locally and nationally, with a big overall goal of developing
these investigator initiated trials.
here at UAB in children's.
Dr. Cross (Host):
Well, this has been so interesting to learn about what you're doing.
For more information, please visit children's al.org
and search developmental therapeutics program.
That's children's al.org
and search developmental therapeutics program.
That concludes this episode of Children's of Alabama PedsCast.
If you found this podcast helpful, please share it on your social channels and
be sure to check out the entire podcast library For other topics that might be
of interest to you, please remember to subscribe, rate, and review this podcast.
Thank you for listening to this episode of PedsCast.
I'm your host, Dr.
Cory Cross.